Piper Sandler on Ventyx Biosciences Inc (VTYX): 'We Remain Bullish on Robust NLRP3 Portfolio'
Tweet Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $21.00 price target on Ventyx Biosciences Inc (NASDAQ: VTYX).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
